Sign in
4

Changes in Ownership

IN8BIO, INC. Filed Acc 0001415889-24-024871

Chief Operating Officer acquired 25,316 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rochlin Kate Chief Operating Officer 2024-10-04 Grant or award +25,316 42,874 D
Derivatives
Rochlin Kate Chief Operating Officer 2024-10-04 Returned to the company · Series A Warrants (right to buy) −12,295 0 D
Rochlin Kate Chief Operating Officer 2024-10-04 Grant or award · Series A Warrants (right to buy) +12,295 12,295 D
Rochlin Kate Chief Operating Officer 2024-10-04 Grant or award · Series C Warrants (right to buy) +25,316 25,316 D
Loading xslF345X05/form4-10082024_041010.xml…